About MaxWell Biosystems 

Founded in September 2016 as an ETH Zürich spin-off, MaxWell Biosystems is a technology leader providing instrumentation and solutions to boost scientific research and development in neurosciences, stem cell and tissue engineering, ophthalmology, and other fields involving electrogenic cells. MaxOne (single-well) and MaxTwo (multi-well) are easy-to-use systems that equip scientists with the ability to record electrical signals of neurons in in-vitro 2D and 3D models at network, cellular, and subcellular levels. MaxWell Biosystems’ main goal is to be a trusted partner to all users and collaborators, for a greater cause, of advancing scientific breakthroughs and for achieving faster and more effective drug discovery, through our products, solutions, and expertise.

Meet our Management Team

Careers at MaxWell Biosystems 

Have you ever wanted to work with cutting-edge technology involving both engineering and biology? Do you enjoy working in an international, multidisciplinary, and interactive team, be it marketing, operations, research, or product development?

View our Open Positions

Want to Learn More? 

Contact our Field Application Scientists today to learn more about our HD-MEA solutions. With our technology you can discover the function of your neurons at the network, cellular and subcellular level. You can use our HD-MEAs for your research, disease modelling and drug discovery.

Get Started

Supported By